Malignant neoplasm of ovary, including Hilmo

C3_OVARY_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C56 Hospital discharge: ICD-9 — 183 Hospital discharge: ICD-8 — 1830 Cause of death: ICD-10 — C56 Cause of death: ICD-9 — 183 Cause of death: ICD-8 — 1830 Cancer registry: Topography ICD-O-3 — C56 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2526
4. Check minimum number of events None	2526
5. Include endpoints None	2526
6. Filter based on genotype QC (FinnGen only)	2426

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_OVARY_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C56
HD_ICD_9	183
HD_ICD_8	1830
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C56
COD_ICD_9	183
COD_ICD_8	1830
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C56
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of ovary, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2426	2426	-
Unadjusted period prevalence (%)	0.86	0.86	-
Median age at first event (years)	61.88	61.88	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2526: Matched controls
25260

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2521.9

307.7

557

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

532.8

307.7

327

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

4446.4

307.7

685

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

21.0

307.7

575

349

B01AB10

ATC

tinzaparin; parenteral

15.0

307.7

998

1055

JAL30

NOMESCO Finland

Omentectomy

260.7

307.7

861

JEA00

NOMESCO Finland

Appendectomy

18.4

307.7

780

600

WW500

NOMESCO Finland

Blood transfusion

22.1

307.7

333

172

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

307.7

512

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

307.7

773

WX302

NOMESCO Finland

Thoracal epidural anesthesy

42.4

307.7

722

236

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

17.2

307.7

356

239

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

40.9

307.7

858

314

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

5.8

307.7

767

1769

LCD00

NOMESCO Finland

Hysterectomy

10.5

307.7

674

845

H02AB02

ATC

dexamethasone; systemic

193.5

307.7

1278

133

N02AA05

ATC

oxycodone; systemic

5.5

307.7

854

2129

A03FA01

ATC

metoclopramide; systemic, rectal

17.8

307.7

1619

2301

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

53.8

307.7

274

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

7876.5

307.7

614

Z51.5

ICD-10 Finland

Palliative care

23.5

307.7

624

348

L03AA14

ATC

lipegfilgrastim; parenteral

3685.3

307.7

333

L03AA13

ATC

pegfilgrastim; parenteral

7012.2

307.7

562

R18

ICD-10 Finland

Ascites

60.7

307.7

442

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

327

C56

ICD-10 Finland

Malignant neoplasm of ovary

+∞

307.7

733

JN4AD

NOMESCO Finland

Body CT examination

15.8

307.7

643

534

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

307.7

351

A04AA55

ATC

palonosetron, combinations; systemic

+∞

307.7

407

JAL00

NOMESCO Finland

Biopsy of peritoneum

163.7

307.7

328

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1742.4

307.7

547

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

13.0

307.7

726

758

A04AA02

ATC

granisetron; systemic, transdermal

449.8

307.7

352

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

307.7

1188

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

136.7

307.7

213

128

Kela drug reimbursment

Cancers of female genital organs

16384.0

307.7

1368

A04AA01

ATC

ondansetron; systemic, rectal

44.5

307.7

1059

403

JN4BD

NOMESCO Finland

Extensive body CT

21.7

307.7

737

470

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

26.2

307.7

595

294

L02BG04

ATC

letrozole; oral

66.8

307.7

447

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

20.6

307.7

756

513

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

26.0

295.6

208

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

50.6

293.8

170

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

290.3

273

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

111.4

287.1

147

ZX120

NOMESCO Finland

Intravenous

7.1

278.4

471

789

TPH07

NOMESCO Finland

Cathetrisation of artery

6.1

277.3

563

1131

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

11.9

274.9

293

276

L03AA02

ATC

filgrastim; parenteral

586.5

270.7

264

JAH00

NOMESCO Finland

Laparotomy

14.1

270.1

257

202

B01AB05

ATC

enoxaparin; parenteral

4.1

269.4

1344

5471

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.0

259.4

1405

6011

JAH01

NOMESCO Finland

Laparoscopy

8.3

259.2

368

506

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

258.9

244

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

251.3

237

TPX10

NOMESCO Finland

Implantation of vascular injection port

15.6

248.4

221

154

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

244.9

231

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

11.1

238.5

264

262

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

22.7

232.7

172

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

228.7

216

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

227.6

215

130

Kela drug reimbursment

Malignant tumour

+∞

226.5

214

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

1185.1

225.5

217

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

12.2

222.3

230

206

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

108.5

221.9

114

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2178.3

221.0

211

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

208.3

197

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

206.1

195

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

200.8

190

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

193.2

183

115

Kela drug reimbursment

Breast cancer

+∞

193.2

183

WZC00

NOMESCO Finland

Treatment plan or consultation

3.4

191.4

1181

5236

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

978.7

188.0

182

D70.82

ICD-10 Finland

Drug-induced neutropenia

55.3

186.8

106

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

184.7

175

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

15.4

181.4

161

111

X77

ICPC

Malignant neopl genital female other

+∞

176.1

167

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

+∞

175.1

166

WF049

NOMESCO Finland

Radiotherapy of metastasis

597.4

171.4

168

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

13.5

171.3

164

129

Z31.5

ICD-10 Finland

Genetic counselling

7.2

169.9

268

410

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

18.3

169.0

137

L02BA01

ATC

tamoxifen; oral

441.0

167.7

166

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

11.0

161.3

177

172

PJA12

NOMESCO Finland

Sentinel node biopsy

559.2

160.8

158

JMA10

NOMESCO Finland

Transabdominal total splenectomy

79.9

159.2

HA1AA

NOMESCO Finland

X-ray mammography

6.0

158.9

301

554

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

33.9

158.2

101

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

158.0

150

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.4

157.9

456

1203

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

45.4

155.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

11.7

154.6

162

147

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

153.7

146

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

19.3

152.3

120

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

62.0

151.2

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

31.2

151.2

3009

Kela drug reimbursment

Niraparib

+∞

150.5

143

1510

Kela drug reimbursment

Niraparib

+∞

147.3

140

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

145.2

138

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

25.0

142.9

101

WX402

NOMESCO Finland

General anaesthesia

3.3

142.3

698

2621

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.5

139.4

241

404

JFB46

NOMESCO Finland

Resection of sigmoid colon

16.0

137.4

119

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

136.7

130

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

290.6

135.7

137

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

135.7

129

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

3.4

135.3

595

2083

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

133.5

127

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.3

133.2

114

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

11.1

131.1

142

135

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

130.3

124

L01XK02

ATC

niraparib; oral

+∞

130.3

124

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

129.3

123

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

128.2

122

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

127.2

121

JFF10

NOMESCO Finland

Loop enterostomy

70.9

126.9

XX3DW

NOMESCO Finland

Time consuming IT work

5.1

125.4

282

603

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.1

125.2

691

2757

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

124.0

118

JFB00

NOMESCO Finland

Partial resection of small intestine

13.8

123.4

116

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

123.1

453

1407

ZXE20

NOMESCO Finland

More than three and less than five hours

3.6

121.6

475

1534

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

19.9

121.2

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

13.5

120.1

114

A06AH03

ATC

naloxegol; oral

25.5

119.9

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

119.7

114

ZXC40

NOMESCO Finland

Use of ultrasound

25.2

117.9

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

117.6

112

A04AA03

ATC

tropisetron; systemic

249.6

116.9

119

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

116.6

111

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

114.4

109

J94.8

ICD-10 Finland

Other specified pleural conditions

15.5

110.5

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

+∞

106.0

101

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

106.0

101

JAL31

NOMESCO Finland

Laparoscopic omentectomy

131.4

105.9

113

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

101.6

208

408

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

23.5

101.0

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

139.6

100.9

107

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.3

96.5

168

282

WF002

NOMESCO Finland

Radical radiotherapy

26.0

95.0

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

3.0

94.0

482

1816

A79

ICPC

Malignancy NOS

328.4

93.5

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

942.4

93.5

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

9.3

92.8

113

126

TJA10

NOMESCO Finland

Laparocentesis

166.2

91.8

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

91.2

B03XA02

ATC

darbepoetin alfa; parenteral

10.4

89.8

101

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

140.9

89.6

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

45.1

89.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

89.1

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

14.7

88.9

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

52.0

88.6

JN4CD

NOMESCO Finland

Very extensive body CT

9.1

88.4

110

126

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

87.5

428

1566

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

85.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

184.4

85.8

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

437.1

85.6

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

14.1

84.6

L01BC06

ATC

capecitabine; oral

+∞

83.8

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

83.8

HAC20

NOMESCO Finland

Total mastectomy

151.9

83.6

1511

Kela drug reimbursment

Olaparib

+∞

82.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.4

82.4

169

331

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

27.2

81.9

389

Kela drug reimbursment

Olaparib

+∞

81.7

K56.7

ICD-10 Finland

Ileus, unspecified

9.7

81.7

102

A04AD12

ATC

aprepitant; systemic

415.6

81.4

1XC07, ,

NOMESCO Finland

+∞

79.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

78.5

JFB30

NOMESCO Finland

Right hemicolectomy

16.5

78.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

9.0

75.3

108

L01XK01

ATC

olaparib; oral

+∞

74.3

8480/3-C56.9

ICD-O-3

Mucinous adenocarcinoma of ovary

+∞

73.3

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

72.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

70.8

444

1844

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

10.6

68.7

WZC30

NOMESCO Finland

Teaching

2.8

68.3

398

1589

JFF23

NOMESCO Finland

Transversostomy

20.8

67.2

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

3.4

66.5

257

810

C50.99

ICD-10 Finland

Breast, unspecified

665.2

66.2

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.8

65.7

211

588

WF004

NOMESCO Finland

Palliative radiotherapy

654.7

65.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

64.9

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

225.8

64.5

C574, 8461, 3

ICD-O-3

+∞

63.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

63.8

1224

8023

R50.9

ICD-10 Finland

Fever, unspecified

2.7

63.5

400

1659

JAW96

NOMESCO Finland

Other operation on abdominal wall, peritoneum, mesentery or omentum

27.3

62.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

62.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.2

62.7

172

427

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

319.8

62.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

6.3

62.6

108

179

L02AB02

ATC

medroxyprogesterone; systemic

13.4

62.3

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

623.1

62.1

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

612.6

61.0

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

59.6

JFA70

NOMESCO Finland

Suture of small intestine

27.1

58.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.6

58.0

202

594

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

56.5

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

12.5

55.7

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

55.4

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.3

55.3

221

709

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

4.6

55.3

136

310

JFB20

NOMESCO Finland

Ileocaecal resection

18.6

55.2

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

8.9

53.6

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

53.3

C567, ,

ICD-10 Finland

+∞

52.3

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

20.3

52.2

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

13.5

52.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

51.6

285

1099

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.9

51.2

115

243

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

50.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

50.0

254

936

WF003

NOMESCO Finland

Adjuvant radiotherapy

110.3

50.0

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

49.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

48.9

637

3567

8442/1-C56.9

ICD-O-3

Serous borderline tumor, NOS, of ovary

12.2

48.9

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

48.1

KBV10

NOMESCO Finland

Removal of stent from ureter

12.6

47.9

N02AX02

ATC

tramadol; systemic, rectal

1.8

47.3

1152

7915

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

47.0

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

47.0

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

10.2

47.0

TJF80

NOMESCO Finland

Ostomy education

13.2

45.2

KCH00

NOMESCO Finland

Suture of bladder

15.2

44.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

43.6

162

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

43.5

372

1758

8102

FHL

Second look"" surgery for a malignant tumor

435.0

43.3

LEB00

NOMESCO Finland

Biopsy of vagina

4.6

42.7

102

227

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.7

41.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

40.8

928

6172

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

39.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

39.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

39.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

39.5

1016

6986

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

13.4

39.1

XX1XW

NOMESCO Finland

Extensive written report from radiologist

5.0

38.8

176

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

38.6

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

63.9

38.2

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

383.1

38.1

ZX090

NOMESCO Finland

Other technic of radiotherapy

104.2

37.8

L01CB01

ATC

etoposide; systemic

+∞

37.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

37.6

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

37.6

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

15.2

37.4

Z93.3

ICD-10 Finland

Colostomy status

14.3

37.4

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

36.9

151

490

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

36.9

242

1012

8000/3-C56.9

ICD-O-3

Neoplasm, malignant of ovary

+∞

36.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

36.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

36.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.0

36.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.8

36.2

C50

ICD-10 Finland

Malignant neoplasm of breast

187.7

35.8

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

35.5

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

+∞

35.5

L01XX54

ATC

[U] niraparib

+∞

35.5

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

35.5

1XA02, ,

NOMESCO Finland

+∞

34.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

34.4

8980/3-C56.9

ICD-O-3

Carcinosarcoma, NOS, of ovary

+∞

34.4

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.2

34.3

137

438

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

77.3

33.9

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

33.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

33.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

33.4

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

33.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

33.4

WZC15, ,

NOMESCO Finland

49.5

32.6

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

12.5

32.4

JFA80

NOMESCO Finland

Suture of colon

40.7

32.2

K56.0

ICD-10 Finland

Paralytic ileus

8.1

32.0

R11

ICD-10 Finland

Nausea and vomiting

2.2

32.0

279

1322

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

6.9

31.8

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

6.3

31.7

JFB43

NOMESCO Finland

Left hemicolectomy

12.5

31.5

A98

ICPC

Health maint/preventive medicine

0.5

31.5

2199

23601

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

31.3

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

60.8

31.1

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

4.1

30.9

211

SPAT1153

SPAT

Removal of sutures

1.7

30.6

810

5522

R4190

NOMESCO Finland

Nutritional therapy

3.8

30.5

249

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

30.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

30.3

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

+∞

30.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

29.8

235

1065

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

6.1

29.4

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

29.2

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

29.2

L02BG03

ATC

anastrozole; oral

+∞

29.2

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

44.3

28.7

ZX080

NOMESCO Finland

Image guided radiotherapy

151.7

28.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

28.2

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

10.4

28.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

28.0

126

432

A02BC02

ATC

pantoprazole; systemic

1.6

27.7

1763

14763

S18

ICPC

Laceration/cut

1.6

27.5

1114

8382

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

35.5

27.4

JN6AD

NOMESCO Finland

CT of torso and neck

9.3

27.4

8140/3-C56.9

ICD-O-3

Adenocarcinoma, NOS, of ovary

+∞

27.1

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

27.1

JBA20

NOMESCO Finland

Transabdominal partial excision of diaphragm

+∞

27.1

C48.00

ICD-10 Finland

Malignant tumor of the retroperitoneal space without histology

+∞

27.1

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

27.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

26.9

274

1377

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.7

26.7

244

ZX121

NOMESCO Finland

Central venous catheter

97.8

26.7

B01AB04

ATC

dalteparin; parenteral

2.7

26.5

152

594

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

26.4

253

1241

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

4.0

26.3

187

XX2RW, ,

NOMESCO Finland

8.4

26.1

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

26.1

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

26.1

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

26.1

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

26.1

RS220, ,

NOMESCO Finland

5.5

26.0

ZXC96

NOMESCO Finland

Robot assisted procedure

6.2

25.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

73.5

25.8

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.1

25.7

177

8620/1-C56.9

ICD-O-3

Adult granulosa cell tumor of testis of ovary

136.4

25.6

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

6.5

25.6

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.9

25.6

361

2033

TPX15

NOMESCO Finland

Removal of vascular injection port

33.4

25.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

6.2

25.4

ZX112

NOMESCO Finland

Subcutaneous

6.5

25.2

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

25.0

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

25.0

N02AA01

ATC

morphine; systemic, rectal

6.1

24.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.4

24.4

141

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

22.2

24.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

24.1

109

375

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

24.0

9080/3-C56.9

ICD-O-3

Teratoma, malignant, NOS, of ovary

+∞

24.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

24.0

X76

ICPC

Malignant neoplasm breast female

87.6

23.7

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

242.2

23.7

3AA13, ,

NOMESCO Finland

242.2

23.7

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.0

23.4

167

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

23.4

216

1044

R2110

NOMESCO Finland

Giving the first information

2.2

23.3

212

1019

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.7

23.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

22.9

L02BA03

ATC

fulvestrant; parenteral

+∞

22.9

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

22.9

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

22.9

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

22.7

412

2502

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

232.0

22.7

X81

ICPC

Genital neopl female other/unspecif

26.1

22.6

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

22.6

123

468

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

23.1

22.6

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

20.9

22.6

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

22.2

240

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

6.9

22.1

L01XX46

ATC

[U] olaparib

+∞

21.9

L02BG06

ATC

exemestane; oral

+∞

21.9

1CD02, ,

NOMESCO Finland

+∞

21.9

N02BE01

ATC

paracetamol; systemic, rectal

1.9

21.8

2279

20862

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

221.8

21.6

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.8

21.5

KA1FN

NOMESCO Finland

Isotope renography

8.8

21.5

C10AA07

ATC

rosuvastatin; oral

0.6

21.5

441

6645

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

31.4

21.5

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

23.3

21.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

21.2

477

3072

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

60.5

20.9

LAF17

NOMESCO Finland

Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

+∞

20.9

8010/3-C56.9

ICD-O-3

Carcinoma, NOS, of ovary

+∞

20.9

D69.5

ICD-10 Finland

Secondary thrombocytopenia

21.7

20.8

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

20.7

241

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

22.5

20.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.8

20.0

159

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

23.6

19.9

LCD30

NOMESCO Finland

Radical hysterectomy

58.0

19.9

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

19.9

242

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

19.8

C48.20

ICD-10 Finland

Malignant tumor in unspecified localization in the peritoneum without histology

+∞

19.8

8461/3-C48.2

ICD-O-3

High grade serous carcinoma of peritoneum, NOS

+∞

19.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

19.8

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

19.8

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

6.3

19.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

74.1

19.7

WX600

NOMESCO Finland

Single shot through catheter

4.9

19.7

Z51.0

ICD-10 Finland

Radiotherapy session

105.9

19.6

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.8

19.3

Z2446

NOMESCO Finland

Social worker

2.3

19.1

147

659

SPAT1109

SPAT

Analgesia with portable analgesic pump

14.9

18.9

TGA30

NOMESCO Finland

Thoracocentesis

14.9

18.9

9060/3-C56.9

ICD-O-3

Dysgerminoma of ovary

+∞

18.8

8440/3-C56.9

ICD-O-3

Cystadenocarcinoma, NOS, of ovary

+∞

18.8

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

191.4

18.6

WX892

NOMESCO Finland

Monitored bed care

2.2

18.3

167

802

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.5

18.2

Z51.88

ICD-10 Finland

Other specified medical care

3.4

18.2

199

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

25.2

18.2

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

33.1

18.0

JFF30

NOMESCO Finland

Other colostomy

33.1

18.0

JFF13

NOMESCO Finland

Terminal enterostomy

33.1

18.0

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.3

17.9

109

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

17.7

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

17.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

17.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

95.7

17.6

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

7.8

17.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

17.1

904

6991

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

31.7

17.0

WPB10

NOMESCO Finland

Making a convalescent care decision

25.8

16.9

SPAT1125

SPAT

Stoma care and guidance

3.8

16.7

137

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

16.7

C76.3

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Pelvis

+∞

16.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

16.7

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

16.7

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

16.7

ZZR00

NOMESCO Finland

Flap of skin

6.5

16.7

JN3DM

NOMESCO Finland

Abdominal very extensive MRI examination with 3 Tesla magnet

90.7

16.6

JFB50

NOMESCO Finland

Other resection of colon

23.2

16.4

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

6.1

16.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.9

16.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

16.3

104

KBV00

NOMESCO Finland

Insertion of stent into ureter

11.7

16.0

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

47.8

16.0

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

14.6

15.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

15.6

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

15.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

15.6

HAC25

NOMESCO Finland

Radical mastectomy

+∞

15.6

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

15.6

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

15.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

15.6

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

15.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

15.6

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

15.6

1167

13829

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

17.3

15.6

JBA00

NOMESCO Finland

Transabdominal repair of diaphragm for rupture

85.6

15.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

161.0

15.5

TLE30

NOMESCO Finland

Tamponation of vagina

12.4

15.3

JKA20

NOMESCO Finland

Cholecystectomy

3.0

15.3

238

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

23.5

15.1

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

14.9

141

687

C03CA01

ATC

furosemide; systemic

1.5

14.9

714

5389

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.7

14.9

125

TQW20

NOMESCO Finland

Tatoe

31.9

14.8

8205

FHL

Subradical ovarian malignancy removal (includes possible genital and omet removal)

57.0

14.8

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

5.0

14.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

14.7

140

2668

LWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gynaecological surgery

21.2

14.6

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

14.6

C48.19

ICD-10 Finland

Malignant tumor in specified location in peritoneum other or unspecified histlogy

+∞

14.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

14.6

GAE03

NOMESCO Finland

Suture of chest wall

+∞

14.6

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

14.6

1CD01, ,

NOMESCO Finland

+∞

14.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

14.6

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

80.6

14.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

80.6

14.6

JFC20

NOMESCO Finland

Other enterocolostomy

150.8

14.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

14.2

139

N83.5

ICD-10 Finland

Torsion of ovary, ovarian pedicle and fallopian tube

5.7

14.1

Z3231

NOMESCO Finland

Registered nurse

1.5

14.1

577

4216

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

42.7

14.1

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

10.9

14.0

R06AE07

ATC

cetirizine; oral

1.4

14.0

1139

9407

C10AA05

ATC

atorvastatin; oral

0.7

13.9

646

8370

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

30.2

13.9

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

10.5

13.7

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

75.5

13.6

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

75.5

13.6

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.0

13.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

13.6

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

13.6

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

13.6

D64.2

ICD-10 Finland

Secondary sideroblastic anaemia due to drugs and toxins

+∞

13.6

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

13.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

13.6

D77

ICPC

Malignant digestive neopl other/NOS

140.7

13.5

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

140.7

13.5

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.3

13.4

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

21.3

13.3

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

21.3

13.3

D39.18

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with other definite histology

40.3

13.2

A06AD11

ATC

lactulose; oral

1.6

13.1

351

2338

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

13.1

1332

15255

JFB40

NOMESCO Finland

Resection of transverse colon

50.3

12.8

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

14.1

12.7

L15

ICPC

Knee symptom/complaint

0.7

12.7

372

5285

K83.1

ICD-10 Finland

Obstruction of bile duct

4.8

12.6

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.8

12.6

5703

FHL

Removal of lymph nodes from the retroperitoneal space

70.2

12.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

32.2

12.6

1DB01, ,

NOMESCO Finland

+∞

12.5

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

12.5

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

12.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

12.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

12.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

12.5

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

12.5

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

12.5

C569, ,

ICD-10 Finland

+∞

12.5

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

12.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

12.5

D39.13

ICD-10 Finland

Uncertain growth nature of the ovarian tumor, sex chord derived

+∞

12.5

M01AH05

ATC

etoricoxib; oral

0.7

12.5

1153

13453

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

9.3

12.5

ZZR10

NOMESCO Finland

Flap of skin and muscle

20.1

12.4

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

130.6

12.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

130.6

12.4

M54.5

ICD-10 Finland

Low back pain

0.7

12.4

547

7193

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.7

12.4

103

C10AX09

ATC

ezetimibe; oral

0.5

12.3

147

2617

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.5

12.3

1978

NK6AN

NOMESCO Finland

Total body bone isotope imaging

11.7

12.3

M79.6

ICD-10 Finland

Pain in limb

0.7

12.2

725

9070

WX704

NOMESCO Finland

Intubation

1.8

12.2

171

956

R03AC02

ATC

salbutamol; inhalant

0.7

12.2

996

11854

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

26.8

12.0

J01DB01

ATC

cefalexin; oral

1.4

12.0

1960

17897

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

11.9

113

552

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

11.9

167

934

N05CF01

ATC

zopiclone; oral

1.4

11.9

803

6387

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

46.9

11.9

GAE06

NOMESCO Finland

Excision of lesion of chest wall

46.9

11.9

WX320

NOMESCO Finland

Spinalanesthesy

0.6

11.7

318

4599

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.1

11.6

109

530

D39.12

ICD-10 Finland

Granulosa cell tumor of uncertain nature in the ovary

65.3

11.6

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

65.3

11.6

KA3EB

NOMESCO Finland

Antegrade pyelography

11.1

11.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.1

11.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

11.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

11.5

JA3HT

NOMESCO Finland

Tissue sample of abdominal tissue change under UA control

+∞

11.5

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

+∞

11.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

11.5

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

11.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

11.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

11.5

A21

ICPC

Risk factor for malignancy

120.6

11.4

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

120.6

11.4

JAL23

NOMESCO Finland

Excision of local lesion of pelvic wall

120.6

11.4

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.8

11.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

11.3

574

4345

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

3.8

11.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

11.1

394

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.7

11.0

324

4618

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.5

11.0

107

L13

ICPC

Hip symptom/complaint

0.6

10.9

288

4201

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

12.0

10.8

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

28.1

10.7

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.7

1020

8515

LAE10

NOMESCO Finland

Unilateral oophorectomy

5.6

10.7

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

10.7

166

ZX100

NOMESCO Finland

Oral

3.9

10.7

D27.93

ICD-10 Finland

Benign ovarian tumor, sex chord stroma derived

60.3

10.6

SDA03

NOMESCO Finland

Periodontal treatment

0.7

10.6

608

7695

M70.6

ICD-10 Finland

Trochanteric bursitis

0.6

10.5

220

3383

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.0

10.5

JAD10

NOMESCO Finland

Repair of incisional hernia

4.5

10.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

110.5

10.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

110.5

10.4

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

10.4

8310

FHL

Radical hysterectomy (includes lymph node removal)

+∞

10.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

10.4

8441/2-C57.0

ICD-O-3

Serous intraepithelial carcinoma of fallopian tube

+∞

10.4

9071/3-C56.9

ICD-O-3

Yolk sac tumor, NOS, of ovary

+∞

10.4

C57.7

ICD-10 Finland

Malignant neoplasm: Other specified female genital organs

+∞

10.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

10.4

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

10.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

10.4

9110/3-C56.9

ICD-O-3

Mesonephroma, malignant of ovary

+∞

10.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

1501

Kela drug reimbursment

Palbociclib

+∞

10.4

394

Kela drug reimbursment

Palbociclib

+∞

10.4

C54.0

ICD-10 Finland

Malignant neoplasm: Isthmus uteri

+∞

10.4

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

10.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

10.4

K02.1

ICD-10 Finland

Caries of dentine

0.8

10.4

958

11315

A28

ICPC

Limited function/disability NOS

1.5

10.3

422

3065

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

12.1

10.3

Z93.2

ICD-10 Finland

Ileostomy status

8.8

10.3

Z93

ICD-10 Finland

Artificial opening status

23.5

10.2

L08

ICPC

Shoulder symptom/complaint

0.7

10.2

302

4309

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.0

10.2

154

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.2

620

4829

D27.92

ICD-10 Finland

Benign granulosa cell tumor in ovary (ovary)

8.5

10.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

10.0

178

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.9

145

822

R01AD12

ATC

fluticasone furoate; nasal

0.7

9.9

437

5790

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

9.9

N05AD01

ATC

haloperidol; systemic

2.4

9.8

280

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

9.8

131

WPA13

NOMESCO Finland

Palliative consultation

10.7

9.8

LAE20

NOMESCO Finland

Bilateral oophorectomy

4.7

9.8

D27.98

ICD-10 Finland

Benign tumor of the ovary (ovary), other specified histology

4.1

9.7

LBE00

NOMESCO Finland

Salpingectomy

3.9

9.6

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

11.4

9.6

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

3.6

9.5

N80.1

ICD-10 Finland

Endometriosis of ovary

2.3

9.5

310

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

3.5

9.5

JFC00

NOMESCO Finland

Entero-enterostomy

100.4

9.4

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

100.4

9.4

Z01.2

ICD-10 Finland

Dental examination

0.8

9.4

745

9030

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

30.1

9.4

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

30.1

9.4

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

9.4

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

9.4

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

+∞

9.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

9.4

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

9.4

C48.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum

+∞

9.4

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

9.4

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

9.4

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

9.4

X75

ICPC

Malignant neoplasm cervix

+∞

9.4

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

9.4

D630, C5671,

ICD-10 Finland

+∞

9.4

C48.09

ICD-10 Finland

Malignant tumor of the retroperitoneal space other or unspecified tumor

+∞

9.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

9.4

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

9.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.4

9.4

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

12.4

9.4

B03XA01

ATC

erythropoietin; parenteral

4.7

9.3

UKC02

NOMESCO Finland

Cystoscopy

1.6

9.3

244

1616

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

10.7

9.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

9.2

447

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

9.1

290

LCC10

NOMESCO Finland

Supravaginal hysterectomy

3.5

9.1

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.8

9.1

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

15.6

9.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

36.8

9.0

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

36.8

9.0

M25.5

ICD-10 Finland

Pain in joint

0.7

9.0

526

6678

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

10.1

9.0

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

10.1

9.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

8.9

490

6284

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

18.7

8.9

D75

ICPC

Malignant neoplasm colon/rectum

18.7

8.9

SPAT1076

SPAT

Cannulation of central vein

24.1

8.9

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.2

8.9

107

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

8.8

156

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.5

8.8

208

L02AE02

ATC

leuprorelin; implant, parenteral

3.8

8.8

G02BA03

ATC

plastic IUD with progestogen

0.5

8.7

1769

SPAT1269

SPAT

Other puncture and/or drainage

7.2

8.7

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.2

8.7

JAH96

NOMESCO Finland

Other opening of peritoneal cavity

50.2

8.7

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.7

8.6

361

4840

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

8.2

8.6

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

27.6

8.5

H01CB02

ATC

octreotide; parenteral

27.6

8.5

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

90.4

8.4

D48.41

ICD-10 Finland

Ovarian tumor of uncertain or unknown nature in the peritoneum

90.4

8.4

JFC10

NOMESCO Finland

Ileotransversostomy

90.4

8.4

Y60.8

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care

12.8

8.4

L01CA04

ATC

vinorelbine; systemic

+∞

8.3

D39

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of female genital organs

+∞

8.3

C90.0

ICD-10 Finland

Multiple myeloma

+∞

8.3

C579, 8461, 3

ICD-O-3

+∞

8.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

8.3

C54.23

ICD-10 Finland

Carcinosarcoma

+∞

8.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

8.3

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

8.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

8.3

L01EF01

ATC

palbociclib; oral

+∞

8.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

8.3

WPA42

NOMESCO Finland

Family-centered psychosocial intervention in palliative care

+∞

8.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

8.3

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

8.3

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

8.3

C48.10

ICD-10 Finland

Malignant tumor in specified location in the peritoneum without histology

+∞

8.3

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

+∞

8.3

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.6

8.3

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.9

8.3

128

R96

ICPC

Asthma

0.6

8.3

109

1890

UJF32

NOMESCO Finland

Coloscopy

1.3

8.2

586

4654

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

8.2

2162

20419

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

8.2

118

M54.4

ICD-10 Finland

Lumbago with sciatica

0.7

8.1

231

3334

J94.9

ICD-10 Finland

Pleural condition, unspecified

8.1

XX1AD

NOMESCO Finland

Other CT-examination

33.5

8.1

SPAT1290

SPAT

Preparation of deceased person

33.5

8.1

JGA60

NOMESCO Finland

Suture of rectum

17.2

8.1

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

11.7

8.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

11.7

8.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

8.0

962

11127

WGA11

NOMESCO Finland

Planning of pain management

8.9

8.0

TQB05

NOMESCO Finland

Puncture of skin of trunk

10.1

8.0

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.1

8.0

380

L03

ICPC

Low back symptom/complaint

0.7

8.0

448

5743

G03AC03

ATC

levonorgestrel; oral, implant

0.6

8.0

162

2517

R03DC03

ATC

montelukast; oral

0.7

8.0

221

3208

L17

ICPC

Foot/toe symptom/complaint

0.7

8.0

468

5957

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

8.0

444

5695

R01AD58

ATC

fluticasone, combinations; nasal

0.7

7.9

314

4262

SFA20

NOMESCO Finland

Two-surface restoration

0.8

7.9

1021

11712

Z2221

NOMESCO Finland

Medical doctor

1.3

7.9

577

4597

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

13.1

7.9

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

13.1

7.9

8472/1-C56.9

ICD-O-3

Mucinous cystic tumor of borderline malignancy of ovary

7.8

7.9

R06AX27

ATC

desloratadine; oral

0.7

7.8

419

5411

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

7.8

196

D39.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other female genital organs

8.5

7.8

KBH20

NOMESCO Finland

Replantation of ureter

10.8

7.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.6

7.8

150

2358

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.4

7.8

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.8

7.8

112

634

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

45.1

7.7

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

45.1

7.7

WPA40

NOMESCO Finland

Individual-centered psychosocial intervention in palliative care

45.1

7.7

G03FA01

ATC

norethisterone and estrogen; systemic

0.7

7.6

295

4023

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

7.6

192

2844

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

7.6

157

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

7.6

371

4866

HAE99

NOMESCO Finland

Other reconstruction of breast

11.9

7.6

D82

ICPC

Teeth/gum disease

0.8

7.6

545

6745

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

25.1

7.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

80.3

7.4

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

80.3

7.4

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

80.3

7.4

P20

ICPC

Memory disturbance

0.6

7.4

180

2686

8380/3-C57.0

ICD-O-3

Endometrioid adenocarcinoma, NOS, of fallopian tube

+∞

7.3

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

+∞

7.3

8441/3-C57.0

ICD-O-3

Serous carcinoma, NOS, of fallopian tube

+∞

7.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

7.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

7.3

192

Kela drug reimbursment

Fulvestrant

+∞

7.3

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

+∞

7.3

8020/3-C56.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of ovary

+∞

7.3

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

7.3

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

7.3

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

+∞

7.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

7.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.3

8461/3-C48.1

ICD-O-3

High grade serous carcinoma of specified parts of peritoneum

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

J91, C5671,

ICD-10 Finland

+∞

7.3

C48.29

ICD-10 Finland

Malignant tumor in unspecified localization in peritoneum other or unspecified histology

+∞

7.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

7.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

D07AC13

ATC

mometasone; topical

1.3

7.3

647

5291

SFA10

NOMESCO Finland

One-surface restoration

0.8

7.3

959

11013

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

7.2

370

4821

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

15.8

7.2

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.8

7.2

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.6

7.2

150

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

7.2

375

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

7.2

941

10820

N06DX01

ATC

memantine; oral

0.5

7.1

1248

2362A

ICD-9 Finland

Neoplasm of uncertain behaviour of genito-urinary organs, Ovary

30.1

7.1

E89.4

ICD-10 Finland

Postprocedural ovarian failure

30.1

7.1

G47.3

ICD-10 Finland

Sleep apnoea

0.7

7.1

217

3094

R74

ICPC

Upper respiratory infection acute

0.7

7.1

437

5539

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

12.1

7.1

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

12.1

7.1

XLD10

NOMESCO Finland

Gynaecological examination

3.5

7.0

D99

ICPC

Disease digestive system other

3.2

7.0

K65.0

ICD-10 Finland

Acute peritonitis

3.4

7.0

J01MA12

ATC

levofloxacin; systemic

1.4

7.0

333

2480

H13

ICPC

Plugged feeling ear

0.7

7.0

233

3264

M01AB05

ATC

diclofenac; systemic, rectal

0.8

7.0

1281

14205

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.9

6.9

113

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.9

6.9

113

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

3.7

6.9

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

6.9

101

575

KC1GB

NOMESCO Finland

Cystography with X-ray

13.8

6.9

S77

ICPC

Malignant neoplasm of skin

13.8

6.9

Z3232

NOMESCO Finland

Midwife

1.7

6.9

117

696

N81.6

ICD-10 Finland

Rectocele

0.6

6.8

114

1856

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

8.3

6.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

6.8

623

5110

Z43.3

ICD-10 Finland

Attention to colostomy

40.2

6.8

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

40.2

6.8

LAB11

NOMESCO Finland

Laparoscopic biopsy of ovary

40.2

6.8

JDE00

NOMESCO Finland

Gastrojejunostomy

40.2

6.8

LAC96

NOMESCO Finland

Other excision or destruction of lesion of ovary

40.2

6.8

J45.9

ICD-10 Finland

Asthma, unspecified

0.7

6.7

275

3718

C10AA01

ATC

simvastatin; oral

0.8

6.7

722

8518

H02

ICPC

Hearing complaint

0.7

6.7

172

2539

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.5

6.7

156

LCF00

NOMESCO Finland

Excision of lesion of parametrium

22.6

6.7

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

4.0

6.6

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.8

6.6

592

7145

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

6.6

752

8818

XX1VW

NOMESCO Finland

Written report from radiologist

3.6

6.6

306

Kela drug reimbursment

Erythropoietin and darbepoetin

12.3

6.6

JFF26

NOMESCO Finland

Sigmoidostomy

12.3

6.6

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

6.6

148

2245

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

6.5

289

2123

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.8

6.5

117

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

6.5

403

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

6.5

214

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.3

6.4

572

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

6.4

365

4689

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

70.0

6.4

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

70.0

6.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

70.0

6.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.3

6.4

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

7.4

6.4

SPAT1088

SPAT

Blood transfusion

7.4

6.4

R42

ICD-10 Finland

Dizziness and giddiness

0.7

6.4

378

4827

G44.2

ICD-10 Finland

Tension-type headache

0.7

6.4

179

2594

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

1.9

6.3

400

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

6.3

268

3606

R4110

NOMESCO Finland

Physiotherapy

1.3

6.3

547

4449

EB4VA, ,

NOMESCO Finland

0.6

6.3

1609

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

6.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.3

8240/3-C56.9

ICD-O-3

Neuroendocrine tumor, NOS, of ovary

+∞

6.3

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

6.3

Z93.8

ICD-10 Finland

Other artificial opening status

+∞

6.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

6.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

6.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.3

KBH06

NOMESCO Finland

Ureteroureterostomy

+∞

6.3

JN4DD

NOMESCO Finland

Scout CT scan of torso

+∞

6.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

6.3

WB313

NOMESCO Finland

Adjuvant multiple therapy of malignancy with biomodifiers

+∞

6.3

V03AF03

ATC

calcium folinate; systemic

+∞

6.3

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

6.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

6.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

6.3

C80.98

ICD-10 Finland

Malignant tumor without specified localization other specified histology

+∞

6.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

+∞

6.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

6.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.3

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

6.3

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

6.3

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

6.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

6.3

KCD10

NOMESCO Finland

Partial cystectomy

26.7

6.2

JFA83

NOMESCO Finland

Excision of lesion of colon

26.7

6.2

T73

ICPC

Neoplasm endocrine other/unspecified

26.7

6.2

R84

ICPC

Malignant neoplasm bronchus/lung

26.7

6.2

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

6.2

569

6858

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.7

6.1

208

2908

LEE00

NOMESCO Finland

Suture of vagina

7.7

6.1

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.7

6.1

171

2481

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.7

6.1

269

3594

T80.2

ICD-10 Finland

Infections following infusion, transfusion and therapeutic injection

12.5

6.1

ZX050

NOMESCO Finland

Stereotactic radiotherapy

12.5

6.1

EB1VA, ,

NOMESCO Finland

0.6

6.0

128

1969

8308

FHL

Hysterectomy and bilateral adnexal removal

2.0

6.0

329

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.6

6.0

121

1883

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1012

533

31.01

307.65

1.8

1.4

457.66

65.81

pmol/l

27.88

974

518

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1756

1175

46.75

307.65

14.3

1.5

152.16

25.74

u/ml

16.40

1729

1113

(4281824) Cell count and differential, peritoneal fluid

707

153

63.78

307.65

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1108

1088

17.36

307.65

2.4

1.4

6.84

2.62

ug/l

3.82

804

802

(4035726) Immunohistochemistry procedure

759

544

19.52

307.65

1.4

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

259

92.98

307.65

5.7

1.3

121.60

66.14

ng/l

—

120

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

352

415

9.69

281.36

2.5

1.8

110.73

18.43

u/ml

1.72

298

331

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

154

40.93

253.39

2.3

1.0

64.99

16.45

u/ml

6.02

148

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

205

128

17.34

244.04

4.4

1.1

22.72

2.94

ug/l

2.14

108

(3024561) Albumin [Mass/volume] in Serum or Plasma

1695

8635

3.93

232.65

6.2

3.5

32.77

36.03

g/l

74.54

1639

7854

(3012095) Magnesium [Moles/volume] in Serum or Plasma

862

2804

4.15

231.99

6.4

2.2

0.78

0.82

mmol/l

16.04

838

2555

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1693

8846

3.77

218.23

3.2

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

1289

5720

3.56

214.27

2.9

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

173

101

18.31

212.56

1.1

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1045

4361

3.38

186.13

2.8

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1731

9890

3.38

178.13

10.4

3.5

8.90

10.37

umol/l

6.58

1680

9158

(3003396) Base excess in Arterial blood by calculation

613

1879

3.99

174.08

6.4

0.68

1.62

mmol/l

7.70

520

1484

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

207

231

9.67

170.88

2.1

364.17

23.20

u/ml

1.42

188

211

(3023368) Bacteria identified in Blood by Culture

1026

4419

3.23

170.45

4.2

3.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

610

1895

3.93

169.57

6.4

6.3

15.92

11.95

kpa

35.33

591

1792

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

610

1897

3.92

169.29

6.4

6.3

5.11

kpa

0.06

591

1800

(40768806) Pleura Pathology biopsy report

129

20.86

169.18

1.3

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

264

426

6.80

158.93

1.7

2.3

3.78

3.47

g/l

2.14

256

402

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

27.93

150.17

1.3

3.0

8465.77

869.11

e6/l

0.72

(3002173) Hemoglobin [Mass/volume] in Arterial blood

513

1531

3.95

149.59

6.6

7.0

113.20

120.02

g/l

14.74

499

1475

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

489

1424

4.02

147.49

1.8

2.1

0.20

0.21

g/l

2.44

462

1300

(3013650) Neutrophils [#/volume] in Blood by Automated count

1802

11236

3.11

145.69

21.9

6.4

3.71

4.05

e9/l

8.93

1573

9592

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

26.32

128.42

1.3

2.4

11021.60

100727.13

e6/l

0.69

(3044007) Cell count panel - Peritoneal fluid

26.45

118.58

1.4

3.0

—

(40768804) Tissue Pathology biopsy report

1330

7737

2.52

111.25

2.6

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

953

4748

2.62

110.78

4.8

3.1

95.15

94.15

0.69

935

4598

(3033799) Differential panel - Peritoneal fluid

24.36

109.44

1.3

2.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

371

1104

3.77

106.58

8.1

6.7

24.58

24.99

mmol/l

1.38

357

1041

(3019060) Gas panel - Arterial blood

372

1133

3.68

103.09

4.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

116

119

10.17

101.36

1.2

1.4

39.02

27.15

g/l

11.34

108

100

(3018405) Lactate [Moles/volume] in Arterial blood

255

602

4.60

100.08

5.1

3.7

1.31

1.36

mmol/l

0.26

255

587

(3016502) Oxygen saturation in Arterial blood

465

1660

3.21

99.99

6.7

97.31

95.25

10.19

450

1585

(3022217) INR in Platelet poor plasma by Coagulation assay

1457

9149

2.40

98.54

10.3

14.7

1.17

1.23

inr

1.74

382

2632

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

332

977

3.76

96.54

7.5

7.6

0.80

0.70

5.01

332

972

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

332

983

3.74

95.64

7.5

7.6

1.47

1.41

0.52

332

976

(3023199) Leukocytes [#/volume] in Pleural fluid

108

114

9.85

92.38

1.3

1.5

1497.30

2653.26

e6/l

0.52

(3020891) Body temperature

269

704

4.16

92.12

5.8

4.3

—

(3002256) Pathology report gross observation

454

1674

3.09

91.83

1.3

1.1

—

(40758558) Short blood count panel - Blood

898

4748

2.38

87.62

16.6

4.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

10.25

85.59

1.2

1.5

19542.64

88730.59

e6/l

0.54

(3003694) ABO and Rh group [Type] in Blood

896

4780

2.36

85.18

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

404

1461

3.10

84.05

6.1

5.4

1.12

1.33

mmol/l

2.96

398

1426

(3036489) Thrombin time

252

680

4.01

82.52

1.7

1.8

21.14

21.08

0.05

244

581

(3000991) Gas panel - Venous blood

376

1319

3.17

82.31

7.2

6.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

601

2776

2.53

77.67

2.3

1.9

28.82

29.39

1.74

590

2678

(3012441) Differential panel - Pleural fluid

9.96

73.64

1.2

1.5

—

(3042936) Bacteria identified in Isolate by Culture

541

2445

2.54

72.72

1.8

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

412

1639

2.81

71.41

4.8

2.9

253.69

237.78

u/l

1.44

396

1516

(3020779) Urea [Moles/volume] in Serum or Plasma

362

1350

2.96

70.66

8.3

6.4

7.50

9.76

mmol/l

10.04

355

1279

(3020630) Protein [Mass/volume] in Serum or Plasma

392

1580

2.75

65.93

6.1

1.5

64.26

66.91

g/l

9.04

371

1381

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

180

457

4.16

63.74

2.7

3.6

0.36

0.39

u/ml

0.40

273

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1392

9567

2.01

63.17

6.1

4.7

1.18

1.22

mmol/l

50.45

1310

8466

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

15.17

62.32

2.0

3.3

—

(3045788) Cell count panel - Pleural fluid

8.70

60.30

1.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1929

22179

0.45

57.89

4.3

5.2

2.88

2.83

mmol/l

1.64

1713

20341

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1715

20504

0.49

55.99

5.1

5.9

39.72

39.64

mmol/mol

0.12

1541

18891

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2010

16151

2.20

54.98

11.3

5.3

87.66

75.62

u/l

14.48

1926

14855

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

18.55

52.61

1.2

67.43

51.06

1.06

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1469

10706

1.89

51.53

6.5

5.2

1.19

1.23

mmol/l

56.91

1317

9014

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1887

21734

0.48

51.39

3.9

4.7

4.90

4.86

mmol/l

0.96

1684

20031

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1868

21587

0.48

51.28

3.9

4.6

1.58

1.60

mmol/l

1.40

1663

19772

(3013826) Glucose [Moles/volume] in Serum or Plasma

1600

12030

1.90

50.43

5.6

3.8

6.73

6.64

mmol/l

1.35

1529

11108

(3015377) Calcium [Moles/volume] in Serum or Plasma

1074

7158

1.87

49.22

5.5

2.1

2.35

2.37

mmol/l

2.50

994

6035

(3031040) Bacteria [#/volume] in Urine by Automated count

1841

14722

1.92

45.27

5.7

4.9

1085.90

3016.16

e6/l

1.48

178

(3009261) Glucose [Presence] in Urine by Test strip

1480

11066

1.81

45.12

6.1

4.1

0.00

0.01

estimate

1.32

275

1860

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1002

6690

1.83

44.39

3.5

2.2

59.48

57.51

u/l

0.24

944

6048

(3021601) Nitrite [Presence] in Urine by Test strip

1464

10974

1.79

43.60

8.6

5.4

0.00

estimate

0.50

261

1850

(3026008) Bacteria identified in Urine by Culture

1146

7996

1.79

43.59

3.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1902

21640

0.51

42.52

4.5

4.8

5.87

mmol/l

0.05

1701

19640

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

172

574

3.14

40.13

1.9

1.8

2.01

1.18

ug/l

0.61

165

484

(3035880) pH of Pleural fluid

10.16

39.86

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1809

20816

0.54

39.47

3.6

4.1

1.30

1.27

mmol/l

1.52

1589

18842

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

949

6402

1.77

39.39

6.9

2.5

33.43

29.38

u/l

0.69

909

6018

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

144

446

3.36

37.96

1.4

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1866

21211

0.54

37.19

5.4

2.10

2.00

mu/l

0.60

1687

19435

(3018095) Leukocytes [#/volume] in Urine

1016

7141

1.71

35.42

5.4

3.5

96.89

120.94

e6/l

0.47

677

4759

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

287

1334

2.30

34.52

1.5

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

207

4.37

34.34

3.0

1.4

0.18

0.34

nmol/l

2.84

163

(3002582) Erythrocytes [#/volume] in Urine

844

5799

1.68

31.01

3.1

47.95

59.99

e6/l

0.40

627

4309

(40768793) Breast Pathology biopsy report

178

4.43

30.73

1.4

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

29.22

1.1

0.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

494

2964

1.83

29.00

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

385

2138

1.94

28.72

2.6

2.0

6.39

6.29

umol/l

0.04

327

1773

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

131

457

2.97

28.25

2.1

2.0

118.68

2652.13

u/l

3.61

196

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

188

824

2.38

25.70

8.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

219

1031

2.23

25.33

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

771

5398

1.62

25.19

6.5

4.1

—

(3030467) Casts [#/volume] in Urine by Automated count

773

5421

1.61

25.06

3.1

3.0

0.56

0.42

e6/l

0.63

562

4043

(36304419) Bacteria [Presence] in Urine

759

5308

1.61

24.85

3.0

2.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

398

6309

0.56

24.16

1.6

1.47

1.34

mmol/l

2.58

349

5261

(3015736) pH of Urine

1135

8800

1.53

23.13

6.0

3.8

5.85

5.88

0.10

508

(3003458) Phosphate [Moles/volume] in Serum or Plasma

388

2305

1.81

23.10

4.7

4.4

1.02

1.04

mmol/l

1.15

360

2080

(3035350) Ketones [Presence] in Urine by Test strip

1355

10939

1.51

22.61

6.5

4.1

0.00

estimate

1.23

283

2037

(3018418) pH of Serum or Plasma

863

6340

1.55

22.34

3.3

3.1

7.40

0.25

119

1064

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

255

3.33

22.19

1.2

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1621

18501

0.65

21.53

4.6

4.5

15.09

14.85

pmol/l

3.44

1454

16807

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

316

1803

1.86

21.35

2.1

31.42

37.27

u/l

1.24

272

1528

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

399

2467

1.73

20.53

2.2

2.5

21.13

22.00

0.64

337

2035

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

506

3336

1.65

20.45

2.8

2.5

2.06

1.50

e6/l

0.91

268

1883

(3037467) Urinalysis macro (dipstick) panel - Urine

1761

15200

1.52

20.07

7.4

4.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

347

2074

1.78

20.07

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1188

9487

1.48

19.90

7.2

5.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

345

2072

1.77

19.61

1.7

—

(40761535) Cells panel - Urine sediment

322

1895

1.80

19.60

4.7

3.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

357

2182

1.74

19.05

1.5

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

790

5854

1.51

18.95

6.3

4.7

0.00

estimate

0.32

260

1877

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

209

1080

2.02

18.89

1.5

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

453

2971

1.64

18.51

2.9

2.7

4.54

4.78

e6/l

0.14

222

1525

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

667

4804

1.53

18.16

1.7

2.09

1.05

mg/l

8.91

569

3642

(3018572) Chloride [Moles/volume] in Blood

100

391

2.62

17.44

5.1

7.2

104.60

104.27

mmol/l

0.24

341

(3039000) Anion gap in Blood

100

391

2.62

17.44

5.1

7.2

11.16

11.01

mmol/l

0.16

341

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

117

496

2.42

17.23

2.1

3.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

228

3.08

16.43

1.9

1.3

21.45

17.65

u/l

1.00

176

(3004789) Transferrin [Mass/volume] in Serum or Plasma

410

2696

1.62

16.42

2.3

2.4

2.20

2.41

g/l

10.21

388

2460

(3004809) Band form neutrophils/100 leukocytes in Blood

203

3.21

16.32

2.7

3.2

1.81

1.05

1.09

172

(3027945) Reticulocytes/100 erythrocytes in Blood

310

1902

1.72

16.19

2.1

2.3

2.00

1.81

2.00

288

1639

(3002032) Base excess in Venous blood by calculation

278

1655

1.76

16.16

3.5

3.2

2.50

2.18

mmol/l

0.64

242

1452

(3022948) Iron [Moles/volume] in Serum or Plasma

445

3001

1.59

16.01

2.3

2.4

12.48

13.02

umol/l

0.61

429

2753

(3008757) Leukocyte morphology finding [Identifier] in Blood

139

3.65

15.64

2.7

3.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

276

1664

1.74

15.32

3.5

3.2

5.78

5.85

kpa

0.57

270

1625

(3000850) Epithelial cells [#/volume] in Urine

573

4129

1.50

15.16

2.5

8.26

7.41

e6/l

0.57

520

3652

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

811

10138

0.71

14.39

2.1

2.3

77.82

80.43

nmol/l

1.86

733

8959

(3037121) Protein [Mass/volume] in Urine

130

624

2.14

14.31

6.4

2.3

0.12

0.35

g/l

5.31

167

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

424

2910

1.55

13.98

9.8

6.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

343

2.53

13.95

1.1

1.2

—

(3013115) Eosinophils [#/volume] in Blood

1266

10677

1.37

13.45

6.9

5.5

0.16

0.19

e9/l

9.74

1082

9276

(3001604) Monocytes [#/volume] in Blood

1221

10252

1.37

13.27

6.7

5.4

0.56

e9/l

0.08

1032

8768

(3006315) Basophils [#/volume] in Blood

1223

10289

1.37

13.04

6.7

5.4

0.04

e9/l

2.33

1031

8784

(3019198) Lymphocytes [#/volume] in Blood

1250

10564

1.36

12.89

6.8

5.4

1.81

1.90

e9/l

0.32

1077

9260

(3019069) Monocytes/100 leukocytes in Blood

1142

9526

1.36

12.76

6.6

5.9

8.53

8.34

0.98

1067

8760

(3023520) Reticulocytes [#/volume] in Blood

231

1405

1.71

12.38

2.0

2.3

72.22

71.03

e9/l

0.13

135

1043

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

5.83

12.26

2.8

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

165

912

1.87

12.22

2.4

2.5

0.26

0.27

e6/l

0.02

159

874

(3047181) Lactate [Moles/volume] in Blood

117

577

2.08

12.04

5.2

6.1

1.32

1.23

mmol/l

0.33

102

498

(3024354) Oxygen [Partial pressure] in Venous blood

229

1407

1.69

11.82

3.3

2.7

4.30

4.55

kpa

0.87

223

1370

(3002030) Lymphocytes/100 leukocytes in Blood

1160

9778

1.34

11.76

6.5

5.7

25.89

28.95

13.40

1086

9021

(1761868) Lipid panel - Serum or Plasma

539

7039

0.70

11.59

2.8

3.0

—

(3017181) Myelocytes/100 leukocytes in Blood

253

1607

1.64

11.48

3.3

3.8

1.36

0.64

4.35

142

361

(3021589) Normoblasts [#/volume] in Blood

1089

9117

1.34

11.45

13.4

8.1

0.00

e9/l

0.70

870

7409

(3026782) Osmolality of Urine

518

3844

1.44

11.40

3.3

2.9

493.23

499.23

mosm/kgh2o

0.27

453

3242

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

159

892

1.84

11.24

2.8

2.4

1.27

1.14

0.86

159

883

(3000963) Hemoglobin [Mass/volume] in Blood

2293

23791

0.61

10.88

40.9

18.1

122.37

132.59

g/l

216.84

2264

23394

(3026361) Erythrocytes [#/volume] in Blood

2293

23784

0.61

10.68

40.6

18.0

4.13

4.41

e12/l

129.47

2225

22989

(3035941) MCH [Entitic mass]

2293

23783

0.61

10.65

40.4

17.9

30.17

0.06

2263

23381

(3010813) Leukocytes [#/volume] in Blood

2293

23782

0.61

10.62

40.6

18.0

6.76

6.54

e9/l

2.47

2223

22985

(3022096) Basophils/100 leukocytes in Blood

1086

9156

1.33

10.62

6.4

5.7

0.64

0.71

4.38

1013

8370

(3024731) MCV [Entitic volume]

2293

23780

0.61

10.57

40.4

18.0

91.69

91.08

7.37

2263

23379

(3006504) Eosinophils/100 leukocytes in Blood

1118

9473

1.32

10.52

6.4

5.6

2.33

2.93

19.51

1042

8689

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

154

876

1.81

10.42

2.8

2.3

0.65

0.03

154

870

(3007461) Platelets [#/volume] in Blood

2293

23771

0.62

10.31

40.6

18.0

273.75

261.82

e9/l

10.50

2231

23073

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

251

1637

1.59

10.21

5.5

2.3

59.41

65.12

ml/min/173m2

1.86

128

649

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

137

760

1.85

10.06

4.4

4.9

1.66

1.57

0.61

126

703

(3007930) Methemoglobin/Hemoglobin.total in Blood

137

760

1.85

10.06

4.4

5.0

0.88

0.89

0.06

126

706

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

126

686

1.88

9.82

1.6

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

2293

23753

0.62

9.81

40.4

18.0

37.04

39.40

81.38

2160

21983

(3021879) Hepatitis B virus core Ab [Presence] in Serum

172

1041

1.70

9.40

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

129

3.05

9.39

1.7

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

286

1967

1.51

9.16

3.4

3.1

—

(3018010) Neutrophils/100 leukocytes in Blood

1125

9692

1.29

8.81

6.3

5.5

58.79

56.67

5.11

1054

8918

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

311

4297

0.68

8.78

1.2

1.3

14.03

13.76

u/ml

0.02

123

1630

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

129

737

1.79

8.64

1.7

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

984

8349

1.29

8.62

6.2

4.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

329

4481

0.69

8.56

1.3

45.33

33.24

iu/ml

0.33

105

1483

(3004119) Hemoglobin [Mass/volume] in Venous blood

181

1156

1.61

8.05

2.9

2.8

117.82

128.67

g/l

8.94

176

1124

(3017143) Hepatitis C virus Ab [Presence] in Serum

245

1686

1.50

7.82

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1534

16755

0.78

7.76

3.6

4.4

17.11

12.59

mm/h

17.00

1396

15432

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.04

7.59

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

317

2.11

7.40

1.7

1.6

—

(40768795) Lymph node Pathology biopsy report

6.24

7.23

1.1

—

(40768441) Liver Pathology biopsy report

106

2.95

7.12

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

289

2117

1.41

6.65

1.4

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

833

9652

0.80

6.59

2.0

93.49

99.65

pmol/l

3.22

455

4339

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

353

1.98

6.57

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

353

1.98

6.57

1.2

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

516

4148

1.31

6.49

3.3

2.2

2.50

2.46

mmol/l

12.95

456

3564

(3045142) Bone marrow Pathology biopsy report

124

2.68

6.41

1.3

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

744

6273

1.26

6.40

2.9

1246.79

1184.43

ng/l

0.09

655

5319

(3019150) Specific gravity of Urine by Refractometry

602

4968

1.28

6.15

5.5

4.7

1.01

1.02

kg/l

0.67

760

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

938

8154

1.24

6.10

3.5

3.6

26.70

83.93

ng/l

0.92

699

5435

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

596

4922

1.28

6.04

1.3

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.80

5.83

1.3

2.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

5.80

5.83

6.1

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2230

21426

1.35

5.44

21.2

12.0

35.22

19.94

mg/l

65.42

2028

16400

(3018738) Hemoglobin F/Hemoglobin.total in Blood

16.05

5.41

1.3

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

625

5252

1.25

5.40

2.0

2.3

3.12

2.97

mg/l

0.63

535

4466

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

573

1.67

5.13

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1551

0.62

5.08

2.1

2.4

41.58

28.17

au/ml

—

108

(3051651) Icteric interference index of Serum or Plasma

2.86

5.08

3.3

4.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

218

2928

0.72

5.06

3.9

4.7

30.83

33.87

3.78

137

1940

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.71

4.98

1.4

1.2

—

(3014891) Appearance of Pleural fluid

6.02

4.91

1.1

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

136

2.37

4.90

3.5

2.6

58.93

59.05

0.01

112

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

237

1771

1.37

4.86

2.4

3.46

6.17

ug/l

5.13

206

1501

(3021440) Promyelocytes/100 leukocytes in Blood

212

1557

1.39

4.83

3.6

3.8

0.27

0.07

3.27

100

311

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

171

2372

0.70

4.81

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

131

1904

0.67

4.74

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

7.17

4.65

1.4

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1409

0.63

4.63

1.2

1.3

23.30

46.69

au/ml

—

(21494434) Karyotype in Bone marrow

110

2.47

4.54

1.1

—

(3003181) Sodium [Moles/volume] in Urine

408

1.74

4.54

1.2

1.3

59.77

60.83

mmol/l

0.08

328

(3020682) Albumin/Creatinine [Ratio] in Urine

586

6837

0.81

4.51

3.6

15.41

7.08

mg/mmol

4.32

351

3849

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

431

5196

0.79

4.49

1.2

1.3

0.75

1.79

u/ml

5.13

130

1349

(3012516) Albumin [Mass/volume] in Urine

551

6461

0.81

4.44

3.1

339.61

411.36

mg/l

0.15

329

3629

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

272

1.89

4.41

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

328

1.79

4.19

1.4

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

756

0.52

4.17

1.6

8.35

3.83

mg/l

0.59

564

(3052851) Hemolysis interference index of Serum or Plasma

601

1.57

4.08

2.9

3.1

—

(21494755) Public health laboratory ask at order entry panel

1423

0.65

4.02

1.3

—

(3044889) 12 lead EKG panel

1628

15296

1.18

3.85

4.1

3.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.69

3.82

2.2

2.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

102

684

1.51

3.81

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

677

1.51

3.78

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

201

1.96

3.77

1.4

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

283

3515

0.78

3.76

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

371

1.69

3.72

1.8

1.9

—

(40761536) Microorganisms panel - Urine sediment

223

1723

1.32

3.71

8.1

4.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

691

1.50

3.64

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

108

1543

0.69

3.62

2.0

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

588

6738

0.83

3.62

3.0

6.16

6.25

mmol/l

0.20

492

5623

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

133

1822

0.71

3.51

1.4

1.6

1.37

0.02

113

1602

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

10.02

3.49

1.7

1.3

175.67

147.17

umol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

472

1.58

3.48

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

348

1.68

3.47

2.4

2.7

8.04

8.09

kpa

0.09

340

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

341

1.69

3.44

1.4

1.3

—

(3000492) Spirometry study

142

1914

0.73

3.40

1.5

—

(3025159) Blasts/100 leukocytes in Blood

195

1501

1.32

3.36

3.7

3.9

0.09

0.01

268

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

8.59

3.26

1.2

1.6

—

(3026726) Creatinine [Moles/volume] in Specimen

8.59

3.26

1.0

4.4

50.17

372.86

umol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1093

0.66

3.14

1.9

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

238

1.78

3.10

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

109

775

1.42

3.09

1.5

1.6

1.89

1.60

g/l

1.56

662

(3049717) Cytology report of Urine Cyto stain

448

1.56

3.05

2.8

1.7

—

(3045424) Erythrocytes [Presence] in Urine

382

1.58

2.90

2.1

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

200

1.81

2.85

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

374

4366

0.83

2.76

1.8

1.7

1249.43

1200.11

nmol/l

0.43

273

3245

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

189

1492

1.29

2.75

5.7

2.9

4.41

4.45

pmol/l

0.28

175

1303

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1034

0.68

2.70

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1125

0.69

2.67

1.5

1.6

—

(3048879) Bone marrow aspiration report

3.15

2.64

1.5

1.1

—

(4200892) Spirometry reversibility

128

1681

0.75

2.63

1.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

236

1.71

2.61

1.5

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

236

1.71

2.61

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1170

12494

0.88

2.56

2.6

2.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

189

1507

1.27

2.56

3.7

3.6

1.01

0.50

2.07

331

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

238

1.69

2.54

1.4

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

2.23

2.54

2.1

1.9

75.11

73.73

0.17

(3008898) HLA-B27 [Presence]

709

0.63

2.51

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

204

1.73

2.41

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

360

1.54

2.41

3.9

3.7

62.00

57.37

1.48

360

(3007164) IgA [Mass/volume] in Serum or Plasma

365

4218

0.84

2.39

1.5

1.3

2.00

2.31

g/l

3.95

219

2331

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.12

2.38

1.4

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

588

0.61

2.36

1.3

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.13

2.36

1.1

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1395

13201

1.13

2.32

4.1

2.9

55.01

40.00

u/l

6.95

1295

12060

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

169

1.78

2.32

1.6

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

169

1.78

2.32

1.6

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

547

0.60

2.30

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

627

5647

1.15

2.29

5.6

3.6

—

(3021901) Oxygen saturation in Capillary blood

285

1.59

2.28

2.2

2.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

628

6933

0.87

2.24

2.1

128.74

189.99

u/l

1.74

591

6450

(3042631) Mycobacterium sp identified in Specimen

209

1.68

2.23

2.1

3.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

195

1.70

2.19

1.2

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

120

1546

0.77

2.19

1.4

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

136

1.85

2.17

3.1

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

151

1.80

2.16

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

136

1719

0.78

2.14

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.63

2.14

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.63

2.14

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2250

22918

0.83

2.13

19.3

9.2

23.06

23.20

u/l

0.16

2199

21902

(3020876) Protein [Mass/time] in 24 hour Urine

174

1.73

2.13

1.8

1.7

0.75

1.12

g/24h

0.82

(3004716) Salmonella sp identified in Stool by Organism specific culture

139

1095

1.29

2.11

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

275

3218

0.84

2.09

1.4

1.3

542.50

577.36

titre

0.15

774

(1002224) Polysomnography panel

747

0.68

2.07

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.51

2.05

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.08

1.96

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.08

1.96

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

711

0.68

1.91

1.5

1.8

—

(3004451) EKG impression Narrative

1.93

1.90

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

456

0.61

1.87

1.6

1.7

325.77

346.06

mu/l

0.15

404

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

1.87

0.0

1.9

—

9.39

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1198

0.76

1.85

1.9

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.03

1.85

2.1

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.98

1.85

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.98

1.85

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

198

1.62

1.83

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.13

1.82

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

461

1.40

1.81

4.6

3.7

31.24

24.36

mg/l

0.64

289

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

361

1.45

1.79

1.3

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

151

0.40

1.76

2.3

1.4

—

654.38

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

232

1.56

1.76

1.1

1.3

132.20

119.29

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

112

1409

0.79

1.74

1.3

218.86

178.55

u/ml

0.20

101

1290

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.51

1.74

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

109

858

1.28

1.72

1.6

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

148

0.40

1.63

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

148

0.40

1.63

1.2

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

242

2794

0.85

1.60

1.7

2.0

132.20

123.66

ug/g

0.13

185

2145

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

121

1.74

1.58

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

131

1067

1.24

1.58

1.8

1.5

1.31

1.26

g/l

0.12

118

963

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

125

1013

1.25

1.57

3.9

3.3

2.35

2.10

mmol/l

0.27

774

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

1.67

1.57

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

207

1.55

1.57

2.9

3.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.28

1.55

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

265

1.48

1.53

1.1

1.3

—

12.80

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

870

9258

0.91

1.53

2.6

2.8

180.15

91.64

ug/l

12.51

814

8464

(1761482) Bacteria [#/volume] in Urine by Culture

572

1.32

1.52

5.3

4.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.87

1.50

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

595

0.70

1.50

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.90

1.49

1.5

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

124

1.70

1.47

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

195

1.54

1.45

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

451

4094

1.12

1.45

3.8

3.7

55.46

259.96

ng/l

4.96

365

3103

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2250

22834

0.87

1.45

32.8

13.7

70.18

70.38

umol/l

0.14

2250

22828

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.13

1.44

2.2

1.3

214.80

3654.83

u/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

303

0.59

1.43

1.4

1.6

53.92

58.64

0.20

187

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

919

0.77

1.43

1.5

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

118

1.70

1.41

1.7

1.3

48.32

22.11

umol/l

2.07

111

(3010838) Calcium [Moles/time] in 24 hour Urine

469

0.68

1.39

1.5

2.1

4.23

5.01

mmol/24h

0.96

393

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

143

1704

0.83

1.39

1.1

1.2

112.51

136.53

iu/ml

0.36

670

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

300

0.60

1.39

1.3

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1070

0.79

1.38

1.2

1.4

—

(3009343) pH of Capillary blood

127

1049

1.22

1.37

3.9

3.4

7.43

7.42

0.24

142

(40761511) CBC panel - Blood by Automated count

2190

22253

0.88

1.37

22.7

11.8

—

(1616796) Gas panel - Central venous blood

348

1.39

1.37

3.0

3.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

127

1.66

1.36

1.9

1.7

70.81

75.46

umol/l

0.38

127

(3026470) Cobalt [Mass/volume] in Blood

161

0.50

1.35

1.6

2.0

7.33

3.84

ug/l

—

152

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

257

1.45

1.33

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

257

1.45

1.33

1.3

—

(4034850) Laboratory test

763

1.25

1.33

11.4

9.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

307

0.62

1.31

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

612

0.73

1.29

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

260

1.43

1.27

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.29

1.26

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

397

1.34

1.26

2.5

3.1

24.75

25.29

mmol/l

0.40

390

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

279

0.61

1.25

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

279

0.61

1.25

1.2

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

1.42

1.25

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

278

0.61

1.24

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

278

0.61

1.24

1.2

1.4

—

(3025941) Bacteria identified in Stool by Culture

144

1219

1.19

1.23

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

2.63

1.21

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

570

0.73

1.21

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

322

0.65

1.17

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

265

1.40

1.16

1.1

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

266

1.40

1.14

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

1.14

0.0

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

437

0.71

1.14

2.4

2.3

341.97

65.61

ug/min

0.47

252

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

114

1355

0.83

1.12

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

104

863

1.21

1.12

1.7

1.3

34.99

35.58

iu/l

0.07

759

(3016650) Hepatitis A virus Ab [Presence] in Serum

259

1.40

1.11

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.95

1.08

2.9

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

156

1349

1.17

1.07

2.7

2.5

9.67

10.50

g/l

1.48

144

1233

(3000475) Leukocytes [#/volume] in Synovial fluid

557

0.75

1.07

1.4

1.6

16287.15

9758.85

e6/l

0.60

403

(3040151) Glucose [Moles/volume] in Capillary blood

211

1.43

1.06

2.0

4.3

8.35

6.95

mmol/l

0.71

176

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

314

1.34

1.05

1.5

—

(40768797) Stomach Pathology biopsy report

291

3212

0.89

1.05

1.2

—

(40768443) Skin Pathology biopsy report

932

0.81

1.04

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

150

0.53

1.03

1.0

2.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.06

1.03

1.3

1.1

—

(3010421) pH of Blood

447

1.28

1.02

3.4

3.2

7.42

0.02

409

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

273

1.36

1.01

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

0.45

1.00

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

110

0.45

1.00

1.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

1.53

0.99

1.4

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

1.53

0.99

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

1.53

0.99

1.4

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

157

0.57

0.98

1.6

1.3

6.99

8.08

mmol/l

—

151

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

0.98

1.2

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

10.27

—

(3021788) Differential panel - Synovial fluid

423

0.73

0.97

1.3

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

434

0.73

0.96

1.8

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.80

0.96

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

0.02

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

747

0.80

0.96

2.5

1.4

9.37

10.06

g/l

0.68

633

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

490

0.75

0.95

1.3

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

800

0.81

0.94

3.0

1.4

7.36

7.62

g/l

0.72

695

(3024522) Salmonella sp identified in Specimen by Organism specific culture

268

1.35

0.94

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

799

0.81

0.93

3.0

1.4

3.38

3.67

g/l

1.60

694

(3024869) Neuronal Ab [Presence] in Serum

2.23

0.93

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

463

1.26

0.92

1.1

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

798

0.81

0.92

3.0

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

499

1.25

0.92

2.6

3.4

0.72

0.84

nmol/l

2.18

395

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.73

0.92

2.2

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.73

0.92

2.2

2.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

315

0.70

0.92

1.7

1.6

1.14

0.70

g/l

0.23

236

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

632

0.79

0.92

2.9

1.4

36.29

37.79

g/l

1.07

527

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

208

0.62

0.92

1.5

40.59

37.88

—

123

(3036603) Volume of Urine

134

1.50

0.91

1.3

1.4

1854.20

1821.35

0.06

128

(40760888) Immunoglobulin light chains.free panel - Serum

451

0.75

0.90

3.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

0.49

0.89

1.8

2.5

—

(3016879) Cocaine [Presence] in Urine

336

0.71

0.89

2.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

156

0.58

0.88

1.6

2.1

3.37

3.13

ug/l

—

131

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

111

1.54

0.87

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

180

0.61

0.86

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

287

0.69

0.86

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.82

0.85

1.0

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

669

0.80

0.85

3.6

1.4

0.71

0.35

g/l

0.52

558

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

162

1.42

0.84

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.78

0.84

1.1

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

622

0.80

0.82

1.1

2.48

7.55

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

296

0.71

0.82

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.88

0.81

2.0

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

364

1.27

0.81

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1.47

0.80

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

751

0.82

0.80

3.1

1.4

3.10

2.95

g/l

0.57

646

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.79

0.0

8.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.79

0.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

2.1

—

21.38

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

235

0.68

0.79

1.3

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

270

0.70

0.79

1.2

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.78

0.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

125

0.56

0.77

1.4

1.3

5.82

5.84

mmol/l

—

119

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

0.63

0.76

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

118

1346

0.87

0.76

2.3

2.5

—

(4146454) Self-monitoring of blood glucose

233

0.68

0.76

2.8

2.7

—

(3024928) Oxygen saturation in Venous blood

359

1.26

0.76

1.4

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

108

939

1.16

0.75

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

370

0.75

2.1

1.4

—

(3019977) pH of Arterial blood

1.54

0.75

1.9

2.4

7.45

7.43

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

315

1.27

0.75

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.09

0.74

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

243

0.70

0.74

1.1

—

(3025130) Human papilloma virus identified in Specimen

352

1.25

0.73

1.5

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

242

0.70

0.72

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

367

0.76

0.72

2.1

1.4

—

(3027008) Opiates [Presence] in Urine

366

0.76

0.71

2.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

229

0.70

1.3

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.92

0.70

1.0

—

(3027944) Amphetamines [Presence] in Urine

365

0.76

0.70

2.1

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.71

0.70

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

228

0.70

0.69

1.3

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

239

0.71

0.68

1.0

1.1

1.32

1.42

u/ml

—

121

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.53

0.68

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

171

1889

0.90

0.68

3.1

78.74

82.01

ng/l

0.21

149

1573

(40767503) Oxygen content in Capillary blood by calculation

356

1.24

0.68

2.2

2.5

15.19

16.26

1.18

185

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

118

0.59

0.67

1.0

1.4

1.57

1.64

g/l

—

118

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1024

0.86

0.67

1.2

1.3

0.50

1.11

u/ml

—

100

(3045414) Leukocytes [Presence] in Urine

123

1091

1.13

0.67

2.5

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

679

0.84

0.65

1.5

1.4

259.95

300.96

ug/g

1.08

387

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

764

0.85

0.65

1.6

1.8

—

(3017732) Neutrophils [#/volume] in Blood

164

1484

1.11

0.64

6.8

2.7

6.90

4.79

e9/l

0.53

144

1152

(3006184) Hemoglobin [Mass/volume] in Capillary blood

432

1.21

0.64

1.9

2.1

121.00

128.03

g/l

1.55

313

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

165

0.67

0.63

1.0

1.1

0.13

0.12

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

653

0.84

0.62

1.3

1.5

0.04

0.08

iu/ml

0.54

139

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

0.59

0.62

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

102

0.59

0.62

1.0

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.59

0.61

1.7

180.60

169.97

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

271

1.26

0.61

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

139

1.37

0.60

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.60

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

322

0.77

0.59

1.4

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.54

0.59

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

1873

18460

1.06

0.59

31.5

14.0

15.33

15.12

1.04

1852

18094

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

157

1.34

0.59

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

255

1.26

0.58

1.1

1.2

259.90

260.86

u/ml

0.01

156

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

0.70

0.58

2.5

2.4

3.00

2.52

u/field

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.72

0.57

3.2

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

264

0.76

0.57

1.0

1.1

0.38

0.87

u/ml

—

115

(40757373) Influenza virus identified in Isolate

1.67

0.56

1.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

257

2395

1.08

0.56

1.5

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

457

1.19

0.56

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

330

0.79

0.56

1.0

1.1

0.85

1.95

u/ml

1.14

172

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.62

0.55

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

142

1.34

0.54

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

285

1.23

0.54

2.2

2.7

—

(3016018) Differential panel - Cerebral spinal fluid

216

0.74

0.53

1.2

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.54

0.53

1.3

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

268

1.23

0.52

2.7

2.1

19.83

28.19

mg/l

0.72

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

226

0.75

0.52

1.2

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

280

0.78

0.50

1.0

1.1

1.77

3.26

u/ml

—

114

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

162

1.30

0.50

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.49

1.2

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.49

0.49

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

252

1.23

0.49

2.6

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

155

0.71

0.48

3.5

3.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

392

1.18

0.47

5.9

3.0

1.55

1.56

mg/l

0.04

351

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

165

0.73

0.46

1.3

1.4

—

(3044941) Cell count panel - Synovial fluid

353

0.82

0.46

1.2

1.4

—

(3012501) Base excess in Blood by calculation

375

1.18

0.45

3.3

3.4

3.39

2.56

mmol/l

1.09

265

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

237

1.23

0.45

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2263

22472

1.07

0.45

28.8

14.0

138.94

139.81

mmol/l

42.85

2224

21844

(3004588) Protein electrophoresis panel - Serum or Plasma

129

1406

0.91

0.45

2.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

231

0.78

0.44

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.37

0.44

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

127

0.71

0.43

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

157

1.28

0.43

2.0

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

555

1.14

0.43

1.1

1.2

70.00

107.05

titre

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.38

0.42

1.2

1.5

2.77

3.76

umol/l

0.62

(3051593) INR in Capillary blood by Coagulation assay

0.64

0.42

21.5

10.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

267

1.20

0.42

1.5

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.40

0.42

2.4

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

520

1.14

0.41

1.3

263.67

226.66

miu/ml

0.26

258

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.40

0.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.40

0.0

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

203

1908

1.07

0.39

3.2

1.8

454.54

369.36

nmol/l

4.32

193

1711

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

683

1.12

0.39

1.4

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.34

0.39

1.5

2.1

89.15

100.55

0.66

(3003888) Timothy IgE Ab [Units/volume] in Serum

270

0.81

0.39

1.0

1.1

2.55

2.71

u/ml

—

133

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.39

0.0

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

684

1.11

0.38

5.0

3.5

25.36

25.18

mmol/l

0.19

623

(3028433) Virus identified in Specimen by Culture

1.36

0.38

1.1

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

609

0.88

0.37

3.2

1.5

52.05

38.21

mg/l

0.58

493

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

609

0.88

0.37

3.2

1.5

27.38

28.90

mg/l

0.14

489

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

125

1.28

0.37

1.1

1.07

1.05

ratio

—

(3024263) Appearance of Synovial fluid

116

0.69

0.37

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.64

0.35

7.0

2.6

33.36

28.21

umol/l

—

(3044927) Protein electrophoresis panel - Urine

244

0.82

0.35

1.0

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2265

22522

1.06

0.34

28.5

14.1

3.93

3.94

mmol/l

1.02

2225

21849

(3011648) Oxygen content in Venous blood

145

1.24

0.33

1.5

2.1

9.71

10.97

0.65

145

(3039162) Centromere protein B Ab [Units/volume] in Serum

314

1.15

0.31

1.2

1.3

13.64

48.23

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.35

0.31

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.35

0.31

1.6

1.2

—

(3004775) Volume in Urine collected for unspecified duration

141

0.78

0.29

2.0

2.5

483.40

598.30

—

101

(3034274) Bile acid [Moles/volume] in Serum --fasting

185

1.19

0.29

2.0

1.8

5.17

8.44

umol/l

0.96

125

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

110

0.73

0.28

1.4

1.2

—

7.38

—

(3022145) Colonoscopy Study observation

239

2287

1.05

0.28

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

116

0.78

0.27

2.3

3.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

0.75

0.27

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

161

0.81

0.27

1.1

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

150

0.80

0.27

1.0

1.2

2.02

2.14

mmol/l

0.19

142

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

150

0.80

0.27

1.2

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

204

0.83

0.27

1.2

1.5

5.14

6.84

g/l

—

141

(21494890) Protein electrophoresis panel - 24 hour Urine

159

1.20

0.26

1.7

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.21

0.26

1.0

1.2

—

31.83

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.70

0.26

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.30

0.26

1.2

0.31

g/l

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

203

0.84

0.25

1.2

1.5

0.52

0.37

g/l

—

141

(3028192) IgG subclass 2 [Mass/volume] in Serum

203

0.84

0.25

1.2

1.5

2.34

2.78

g/l

—

140

(4062490) Immunoglobulin typing, IgG

203

0.84

0.25

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.23

0.25

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.23

0.25

1.4

—

(44813793) Dust mix specific IgE antibody measurement

160

1.19

0.25

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.22

0.25

1.1

1.5

2184.89

64.64

nmol/24h

—

(3026493) Urate [Moles/volume] in Serum or Plasma

529

5163

1.03

0.25

2.6

2.1

4121.11

5448.44

umol/l

0.33

471

4398

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.27

0.24

1.2

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.27

0.24

1.9

2.4

35800.00

37996.26

ug/l

0.48

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.73

0.24

2.7

2.5

—

34.00

—

(3022621) pH of Urine by Test strip

147

1545

0.95

0.24

3.2

3.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

117

1237

0.94

0.23

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.28

0.23

1.0

1.1

—

86.29

—

(3052592) Norovirus Ag [Presence] in Stool

1.28

0.23

1.8

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

421

0.90

0.22

1.1

1.4

—

(3022313) Gas panel - Capillary blood

757

1.07

0.22

4.9

3.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.25

0.22

1.2

2.0

1.20

1.19

mmol/l

—

(3017569) Oxygen content in Arterial blood

1.27

0.22

1.3

2.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.22

0.22

1.0

1.1

—

83.14

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

586

0.92

0.22

3.2

1.5

1.29

1.45

ratio

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.0

—

1.00

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

164

1.16

0.20

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.01

—

(4212803) Bone marrow aspirate examination

0.00

0.20

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.23

0.20

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

313

0.89

0.20

1.2

1.3

—

nmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

115

0.78

0.20

1.3

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

365

1.10

0.19

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.21

0.19

1.1

1.2

142.58

143.50

mmol/24h

0.01

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

346

1.10

0.19

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.18

0.19

3.0

2.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.15

0.19

1.0

1.2

—

(3019225) pH of Specimen

228

2207

1.04

0.19

3.5

3.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.18

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

1.14

0.18

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

309

1.10

0.18

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.21

0.18

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.21

0.18

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.21

0.18

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.21

0.18

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

1.20

0.18

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

167

1730

0.96

0.17

3.1

2.8

1.23

1.24

mmol/l

0.39

148

1425

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

236

0.89

0.16

1.2

1.1

54.33

58.97

u/l

0.37

210

(3000012) Reticulocyte production index

204

0.88

0.16

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

204

0.88

0.16

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.13

0.16

1.1

1.2

106.88

115.28

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

302

1.09

0.16

1.2

3.82

4.13

u/ml

0.07

117

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

206

1.12

0.16

2.4

2.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.75

0.15

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.14

0.15

1.0

1.1

2509.56

1707.94

miu/ml

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.14

0.15

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

1.18

0.15

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

213

0.89

0.15

2.8

2.7

87.82

16.92

mg/l

0.48

139

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.08

0.14

3.3

5.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.79

0.14

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.78

0.14

2.4

2.1

—

103.67

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

1.17

0.13

1.5

—

(3008295) Osmolality of Serum or Plasma

218

1.10

0.13

1.0

1.4

271.47

274.13

mosm/kgh2o

0.25

171

(44816559) Phosphatidylethanol [Mass/volume] in Blood

294

0.92

0.13

1.1

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

252

0.91

0.12

1.5

—

19.10

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2042

20353

1.02

0.11

25.3

10.9

79.11

77.74

ml/min/173m2

2.25

1758

16195

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

513

5067

1.02

0.10

1.5

1.7

18182346.75

33527589.39

pmol/l

0.36

418

4128

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

115

1.13

0.10

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.11

0.09

1.2

1.8

—

(3000494) Fungus identified in Specimen by Culture

246

2416

1.02

0.09

1.3

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

183

1868

0.98

0.09

2.6

2.9

121.60

175.72

ng/l

3.68

165

1701

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

726

0.96

0.09

1.3

5.75

47.07

u/ml

—

(3003338) MCHC [Mass/volume]

1798

17921

1.01

0.08

36.2

16.0

328.61

330.53

g/l

18.70

1780

17794

(3029075) Extractable nuclear Ab panel - Serum

1.07

0.08

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.83

0.08

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

154

0.91

0.08

1.0

2.3

6.51

6.78

mmol/l

—

100

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.14

0.08

1.4

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

409

0.95

0.08

1.1

1.3

—

88.57

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

303

1.06

0.07

1.2

5.73

2.98

u/ml

0.26

(3021960) Folate [Moles/volume] in Serum or Plasma

530

5254

1.01

0.07

1.6

1.5

20.11

21.94

nmol/l

2.18

481

4396

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.02

0.07

2.3

2.7

1214.33

821.59

u/ml

—

(3013512) EKG study

656

6514

1.01

0.07

4.3

3.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.89

0.06

1.3

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

138

1.09

0.06

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

376

0.96

0.06

1.1

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

0.93

0.06

1.1

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

649

0.97

0.06

3.3

2.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

286

1.05

0.06

1.6

1.8

1.87

1.63

mmol/l

0.63

280

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

129

1.09

0.05

1.4

1.2

19.50

16.32

u/l

0.19

108

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

287

1.05

0.05

1.1

137.04

121.32

1.10

259

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

110

0.91

0.05

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

110

1.09

0.05

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

171

0.94

0.05

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

0.94

0.04

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

170

0.94

0.04

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

170

0.94

0.04

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

170

0.94

0.04

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

533

0.98

0.04

2.3

2.0

9.69

11.33

mg/l

1.06

482

(40759836) Histone Ab [Presence] in Serum by Immunoblot

169

0.95

0.03

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.09

0.03

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

102

1.08

0.03

1.0

0.63

0.39

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

641

0.98

0.02

1.9

1.8

4.82

4.90

iu/l

0.03

223

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

540

1.02

0.02

1.1

1.5

—

29.21

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

660

0.98

0.02

1.3

1.30

6.53

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

1.08

0.02

1.3

127.20

130.52

nmol/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.08

0.02

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

1.06

0.01

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

123

1.06

0.01

2.3

2.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

362

1.02

0.01

1.2

1.3

—

0.32

nmol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

458

0.98

0.01

1.2

1.4

449.34

1806.99

e6/l

1.21

376

(3000330) Specific gravity of Urine by Test strip

122

1211

1.01

0.01

6.4

3.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

668

0.99

0.01

1.3

6.47

5.67

u/ml

0.07

129

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

853

1.01

0.01

2.0

1.9

40.25

39.79

u/l

0.08

741

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

456

0.99

0.00

1.2

1.4

2.31

24.69

e6/l

2.23

354

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

0.97

0.00

1.5

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.01

0.00

1.0

1.2

—

49.78

—

(3028707) Methadone [Presence] in Urine by Screen method

171

0.99

0.00

1.2

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

419

1.00

0.00

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

539

1.00

0.00

1.2

55.21

44.18

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

194

0.98

0.00

1.1

—

(3011288) Drugs identified in Urine by Screen method

244

0.98

0.00

2.0

1.8

—

(3037756) Immunofixation for Serum or Plasma

364

0.99

0.00

1.6

1.2

—

(3006462) Nitrate [Presence] in Urine

108

1.02

0.00

2.9

3.8

—

(3023410) Appearance of Cerebral spinal fluid

202

0.99

0.00

1.3

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

332

0.99

0.00

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

358

1.01

0.00

1.2

1.3

0.62

3.84

nmol/l

0.50

344

(3010375) cycloSPORINE [Mass/volume] in Blood

0.95

0.00

32.8

23.8

138.67

99.49

ug/l

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.90

-0.00

1.3

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.89

-0.00

1.2

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

4.6

—

357.71

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.1

—

2.72

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

3.2

—

0.99

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

16.58

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

241.33

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.00

-0.00

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.9

—

2.94

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.91

-0.00

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.9

—

18.13

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

625.46

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3015183) Erythrocyte sedimentation rate

0.99

-0.00

1.5

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_OVARY_WIDE – Malignant neoplasm of ovary, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of ovary, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of ovary, including Hilmo (C3_OVARY_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints